Rgenix, Inc.
6Patents
6Active
6Granted
45Portfolio score
Filing activity: Jan 9, 2015 → Apr 19, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9884813B1 | Pharmaceutically acceptable salts of B-guanidinopropionic acid with improved properties and uses thereof | Chemistry; Metallurgy | 8 | Active |
| US9827217B2 | Pharmaceutically acceptable salts of B-guanidinopropionic acid with improved properties and uses thereof | Human Necessities | 7 | Active |
| US10669296B2 | LXR agonists and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US10308597B2 | Inhibitors of creatine transport and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10717704B2 | Inhibitors of creatine transport and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10512623B2 | Pharmaceutically acceptable salts of B-Guanidinopropionic acid with improved properties and uses thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.